Wedge Industrial Co.,Ltd. (SHE:000534)
30.65
+2.79 (10.01%)
Feb 3, 2026, 3:04 PM CST
Wedge Industrial Revenue
Wedge Industrial had revenue of 315.17M CNY in the quarter ending September 30, 2025, with 14.79% growth. This brings the company's revenue in the last twelve months to 1.24B, up 20.40% year-over-year. In the year 2024, Wedge Industrial had annual revenue of 1.08B with 9.93% growth.
Revenue (ttm)
1.24B
Revenue Growth
+20.40%
P/S Ratio
10.82
Revenue / Employee
889.15K
Employees
1,397
Market Cap
13.44B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.08B | 97.43M | 9.93% |
| Dec 31, 2023 | 981.44M | 187.60M | 23.63% |
| Jan 1, 2023 | 793.84M | 137.59M | 20.97% |
| Jan 1, 2022 | 656.26M | 103.69M | 18.77% |
| Dec 31, 2020 | 552.56M | 3.83M | 0.70% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Shyndec Pharmaceutical | 9.36B |
| Zhejiang Medicine | 8.96B |
| Guobang Pharma | 5.94B |
| Zhejiang Jingxin Pharmaceutical | 4.00B |
| Henan Lingrui Pharmaceutical | 3.78B |
| Porton Pharma Solutions | 3.43B |
| Beijing Foyou Pharma CO.,LTD | 3.42B |
| Tibet Rhodiola Pharmaceutical Holding Co. | 2.72B |